透過您的圖書館登入
IP:3.144.109.5
  • 期刊

台灣多囊性卵巢症候群患者中醫藥使用之研究

The Utilization of Traditional Chinese Medicine among Patients with Polycystic Ovary Syndrome in Taiwan

摘要


目的:多囊性卵巢症候群(PCOS)為育齡婦女常見內分泌障礙,現今台灣缺乏大規模中醫藥使用之探討,以期透過本研究了解本病的中醫治療現況。方法:本研究收集2004至2015年長庚醫院北院區之病歷資料,以鹿特丹標準為診斷基礎,追蹤患者後續門診就診之情形。結果:自2004至2015年長庚醫院北院區新符合PCOS診斷標準之患者數幾近逐年增加,後續於追蹤期間內曾使用中醫治療的比率約8.12%。臨床中醫師最常使用的方劑為左歸丸、加味逍遙散與溫膽湯,方劑種類排序分別為補益劑、理血劑和和解劑;最常使用的單味藥為香附、莪朮與丹參,單味藥種類排序分別為理血藥、補益藥和理氣藥。結論:本研究顯示長庚醫院北院區PCOS患者中醫藥之使用情形,以供後續中醫師處方參考。

並列摘要


Objective: Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies in women of reproductive age. However, there is lack of large scale data analysis of the utilization of traditional Chinese medicine (TCM) among patients with PCOS in Taiwan nowadays. Thus, we look forward to investigating the TCM treatment overview in Taiwan. Methods: We collected outpatient department medical records from Chang Gung Research Database (CGRD) of women who fulfilled the revised Rotterdam criteria at Chang Gung Memorial Hospital Linkou, Taipei, and Taoyuan branches between 2004 and 2015 to explore the subsequent utilization of traditional Chinese medicine. Results: In our study, the numbers of the patients who fulfilled the revised Rotterdam criteria at CGMH Linkou, Taipei, and Taoyuan branches between 2004 and 2015 nearly increased every year. Among the patients included, 4227 of them (8.12%) have accepted traditional Chinese medicine treatment after the index date. For herbal formula, the most frequently used patterns were supplementing formula, blood-regulating formula and harmonizing resolution formula respectively. Among all the herbal formula prescriptions, Zou-Gui-Wan was the most commonly used, followed by Jia-Wei-Xiao-Yao-San and Wen-Dan-Tang. For single herb, the most frequently used pattern were blood-regulating herb, supplementing herb and qi-rectifying herb respectively. Among all the single herb prescriptions, Rhizoma Cyperi was the most commonly used, followed by Curcuma Zedoary and Radix Salviae Miltiorrhizae. Conclusion: Our study examined the utilization of TCM among PCOS patients in Taiwan. Those findings may provide some valuable information for the future clinical treatment of PCOS.

參考文獻


Dunaif A, Book CB. Insulin resistance in the polycystic ovary syndrome. Clinical Research in Diabetes and Obesity: Springer; 1997:249-74.
Zawadzki J. Diagnostic criteria for polycystic ovary syndrome (a rational approach). Polycystic ovary syndrome. 1992:377-84.
ESHRE TR, Group A-SPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and sterility. 2004;81(1):19-25.
Group REASPCW. Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome (PCOS). Human reproduction. 2004;19(1):41-7.
Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. The Journal of Clinical Endocrinology & Metabolism. 2006;91(11):4237-45.

延伸閱讀